The Salk Institute and Indivumed: Advancing Global Cancer Research Through Partnership

News   Jan 17, 2018 | Original story from The Salk Institute

 
The Salk Institute and Indivumed: Advancing Global Cancer Research Through Partnership

Salk's CSO Martin Hetzer, Cancer Center Director Reuben Shaw and Director of Business Development Tari Suprapto pictured with Indivumed's Founder and CEO Hartmut Juhl and Managing Director Andrew Deubler. Credit: Salk Institute

 
 
 

RELATED ARTICLES

Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT Biotech

News

Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.

READ MORE

Artificial Cellular Compartments Built

News

How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.

READ MORE

Understanding Lung Cancer Cell Networks Helps Create Drug Treatments

News

A team of scientists has identified networks inside lung cancer cells that will help understand this cancer and fight it with drug treatments.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE